Therapeutics
Seattle Genetics and Millennium to Present Brentuximab Vedotin SGN-35 Clinical Data at the American Society of Clinical Oncology Annual Meeting
Published in Cancer Weekly, June 1st, 2010
Seattle Genetics, Inc. (Nasdaq: SGEN) and Millennium: The Takeda Oncology Company announced that data regarding retreatment experiences with brentuximab vedotin in phase I and phase II clinical trials will be presented during a poster session at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8, 2010 in Chicago, Illinois. The presentation will highlight data from Hodgkin lymphoma and systemic anaplastic large cell lymphoma (ALCL) patients who have been retreated upon relapse after discontinuing previous brentuximab vedotin therapy.
Details of the ASCO presentation are below and the full abstract is available on the ASCO...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-06-01)
More Articles from Cancer Weekly
- Prostate Cancer
Scientists find protein spurs spread of prostate cancer - Pancreatic Cancer
Researchers from University of Nebraska Medical Center detail new studies and findings in the area of pancreatic cancer - Colon Cancer
Data on colon cancer published by researchers at University of North Carolina, Department of Epidemiology - Prostate Cancer
Reports outline prostate cancer research from University of Washington, Department of Urology - Bowel Cancer
Investigators at University of Warwick release new data on bowel cancer - Prostate Cancer
Findings from University of Colorado in prostate cancer reported - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
